Regenxbio Inc. (RGNX) PT Lowered to $100 at Chardan Capital Markets, Following Drug Trial Update

August 4, 2020 2:36 PM

Chardan Capital Markets analyst Gbola ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found